191 related articles for article (PubMed ID: 10449893)
21. Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.
Xia H; Zheng Y; Zhao B; van den Hof S; Cobelens F; Zhao Y
PLoS One; 2017; 12(1):e0169413. PubMed ID: 28081169
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
Yew WW; Chan CK; Chau CH; Tam CM; Leung CC; Wong PC; Lee J
Chest; 2000 Mar; 117(3):744-51. PubMed ID: 10713001
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of low-dose ofloxacin in the treatment of multidrug-resistant tuberculosis in Indonesia.
Mangunnegoro H; Hudoyo A
Chemotherapy; 1999; 45 Suppl 2():19-25. PubMed ID: 10449894
[TBL] [Abstract][Full Text] [Related]
24. Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis.
Lee H; Ahn S; Hwang NY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Kim CK; Koh WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203478
[TBL] [Abstract][Full Text] [Related]
25. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
26. Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China.
Zhang D; Liu B; Wang Y; Pang Y
Trop Med Int Health; 2014 Oct; 19(10):1259-66. PubMed ID: 25040060
[TBL] [Abstract][Full Text] [Related]
27. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
[TBL] [Abstract][Full Text] [Related]
28. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
29. Mycobacterium tuberculosis resistance pattern against first-line drugs in patients from urban area.
Cucunawangsih ; Wiwing V; Widysanto A; Lugito NP
Int J Mycobacteriol; 2015 Dec; 4(4):302-5. PubMed ID: 26964812
[TBL] [Abstract][Full Text] [Related]
30. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
Bai GH; Park YK; Choi YW; Bai JI; Kim HJ; Chang CL; Lee JK; Kim SJ
Int J Tuberc Lung Dis; 2007 May; 11(5):571-6. PubMed ID: 17439684
[TBL] [Abstract][Full Text] [Related]
31. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis.
Abbadi SH; Sameaa GA; Morlock G; Cooksey RC
Int J Infect Dis; 2009 Nov; 13(6):673-8. PubMed ID: 19138546
[TBL] [Abstract][Full Text] [Related]
32. Drug resistance patterns in pulmonary tuberculosis.
Khoharo HK; Shaikh IA
J Pak Med Assoc; 2011 Mar; 61(3):229-32. PubMed ID: 21465933
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of multi-drug resistant tuberculosis].
Okumura M; Kudoh S
Nihon Rinsho; 2011 Aug; 69(8):1394-9. PubMed ID: 21838036
[TBL] [Abstract][Full Text] [Related]
34. [The combination of amoxicillin-clavulanic acid and ofloxacin in the treatment of multidrug-resistant Mycobacterium tuberculosis].
Iwanaga T; Yokota K; Kishikawa R; Ikeda T; Tsurutani H; Hirose T; Nishima S
Kekkaku; 1997 Jan; 72(1):9-13. PubMed ID: 9038010
[TBL] [Abstract][Full Text] [Related]
35. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
[TBL] [Abstract][Full Text] [Related]
36. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
[TBL] [Abstract][Full Text] [Related]
37. High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India.
Selvakumar N; Kumar V; Balaji S; Prabuseenivasan S; Radhakrishnan R; Sekar G; Chandrasekaran V; Kannan T; Thomas A; Arunagiri S; Dewan P; Swaminathan S
PLoS One; 2015; 10(3):e0117421. PubMed ID: 25738956
[TBL] [Abstract][Full Text] [Related]
38. A reduction in anti-tuberculosis drug resistance after the implementation of the national "STOP TB" program in central Taiwan, 2003-2007.
Huang WC; Chen CH; Huang CC; Wu KM; Chiou CS; Lin CF; Chen JH; Shen GH
Jpn J Infect Dis; 2013; 66(2):89-95. PubMed ID: 23514903
[TBL] [Abstract][Full Text] [Related]
39. Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa.
Pietersen E; Anderson K; Cox H; Dheda K; Bian A; Shepherd BE; Sterling TR; Warren RM; van der Heijden YF
PLoS One; 2023; 18(2):e0281097. PubMed ID: 36780443
[TBL] [Abstract][Full Text] [Related]
40. Treatment of multidrug-resistant tuberculosis in Indonesia.
Hadiarto M; Tjandra YA; Hudoyo A
Chemotherapy; 1996; 42 Suppl 3():24-9. PubMed ID: 8980865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
